SDGR

Schrodinger, Inc. · NASDAQ

Sector Technology Services
Industry Packaged Software
Website chrodinger.com
Employees(FY) 800
ISIN US80810D1037

Performance

-13.84%

+7.7%

-5.0%

-15.77%

-46.45%

YTD

-37.15%

Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Advanced Technical Analysis

Technical Analysis of SDGR 2024-11-20

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators and Technical Scores at 43 and 46 suggest a slight bearish bias. Overall, the combined scores imply a cautious outlook, signaling that the stock may be in a consolidation phase.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of SDGR

Stock Rank

Recent News & Updates

2024-11-19 19:30
Schrdinger to Present at Piper Sandler 36th Annual Healthcare Conference(Businesswire)
2024-11-19 08:30
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-11-18 19:30
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-11-18 19:30
Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-11-18 08:30
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative(Business Wire)
2024-11-17 19:30
Schrdinger Broadens and Accelerates Predictive Toxicology Initiative(Businesswire)
2024-11-14 05:58
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag(Simply Wall St.)
2024-11-13 06:56
Schrodinger announces expanded license agreement with Novartis(TipRanks)
2024-11-13 02:06
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...(GuruFocus.com)
2024-11-13 00:54
Q3 2024 Schrodinger Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-12 19:00
SDGR: Raising target price to $18.00(Argus Research)
2024-11-12 11:06
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details(Benzinga)
2024-11-12 08:05
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates(Zacks)
2024-11-12 06:50
Schrödinger Reports Third Quarter 2024 Financial Results(Business Wire)
2024-11-12 06:45
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis(Business Wire)
2024-11-11 17:50
Schrdinger Reports Third Quarter 2024 Financial Results(Businesswire)
2024-11-11 17:45
Schrdinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis(Businesswire)
2024-11-11 07:10
Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect(GuruFocus.com)
2024-11-05 19:00
SDGR: Lowering target price to $14.00(Argus Research)
2024-11-04 08:30
Schrödinger to Present at Jefferies London Healthcare Conference(Business Wire)
2024-11-03 19:30
Schrdinger to Present at Jefferies London Healthcare Conference(Businesswire)
2024-10-31 08:30
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12(Business Wire)
2024-10-30 20:30
Schrdinger to Announce Third Quarter 2024 Financial Results on November 12(Businesswire)
2024-10-23 07:47
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?(Zacks)
2024-10-23 06:01
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium(Business Wire)
2024-10-22 18:01
Schrodinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium(Businesswire)
2024-10-22 18:01
Schrdinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium(Businesswire)
2024-10-17 08:30
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-10-16 20:30
Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-10-16 20:30
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Businesswire)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.